Bio-Techne Corporation (TECH)
NASDAQ: TECH · Real-Time Price · USD
72.28
-0.20 (-0.28%)
Aug 20, 2026, 4:00 PM EDT - Market closed
Bio-Techne Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 1,215 | 1,220 | 1,159 | 1,137 | 1,106 | |
Revenue Growth | -0.38% | 5.23% | 1.97% | 2.81% | 18.75% |
Cost of Revenue | 410.16 | 408.52 | 385.26 | 366.49 | 347.51 |
Gross Profit | 804.88 | 811.12 | 773.8 | 770.22 | 758.09 |
Selling, General & Admin | 452.42 | 446.38 | 428.53 | 396.61 | 391.89 |
Research & Development | 94.77 | 99.5 | 96.66 | 92.49 | 87.14 |
Operating Expenses | 547.18 | 545.88 | 525.19 | 489.11 | 479.03 |
Operating Income | 257.7 | 265.24 | 248.61 | 281.11 | 279.06 |
Interest Expense | - | -8.51 | -15.74 | -11.22 | -11.31 |
Interest & Investment Income | - | 3.89 | 3.32 | 3.41 | 0.79 |
Earnings From Equity Investments | - | 0.94 | -6.84 | -1.14 | - |
Currency Exchange Gain (Loss) | - | 1.45 | -0.73 | 0.68 | 0.7 |
Other Non Operating Income (Expenses) | -11.21 | -0.49 | -0.72 | -0.52 | -0.19 |
EBT Excluding Unusual Items | 246.49 | 262.51 | 227.91 | 272.31 | 269.06 |
Merger & Restructuring Charges | -5.81 | -41.72 | -20.54 | 4.92 | 15.46 |
Gain (Loss) on Sale of Investments | - | - | 0.28 | 49.33 | 15.19 |
Asset Writedown | - | -80.5 | -21.96 | - | -18.72 |
Legal Settlements | - | -41.83 | -3.51 | - | - |
Other Unusual Items | - | - | 3.5 | 12.1 | 20.4 |
Pretax Income | 240.68 | 98.46 | 185.69 | 338.66 | 301.39 |
Income Tax Expense | 58.82 | 25.06 | 17.58 | 53.22 | 38.29 |
Earnings From Continuing Operations | 181.86 | 73.4 | 168.11 | 285.44 | 263.1 |
Minority Interest in Earnings | - | - | - | -0.18 | 8.95 |
Net Income | 181.86 | 73.4 | 168.11 | 285.26 | 272.05 |
Preferred Dividends & Other Adjustments | - | 0.04 | 0.03 | 0.07 | 0.12 |
Net Income to Common | 181.86 | 73.36 | 168.07 | 285.19 | 271.93 |
Net Income Growth | 147.89% | -56.35% | -41.07% | 4.88% | 93.79% |
Shares Outstanding (Basic) | 156 | 158 | 158 | 157 | 157 |
Shares Outstanding (Diluted) | 157 | 160 | 161 | 162 | 164 |
Shares Change | -1.70% | -0.66% | -0.67% | -1.38% | 1.35% |
EPS (Basic) | 1.17 | 0.47 | 1.07 | 1.81 | 1.73 |
EPS (Diluted) | 1.16 | 0.46 | 1.05 | 1.76 | 1.66 |
EPS Growth | 152.17% | -56.19% | -40.34% | 6.02% | 90.81% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | 263.22 | 256.55 | 236.1 | 216.15 | 280.36 |
Free Cash Flow Per Share | 1.68 | 1.61 | 1.47 | 1.33 | 1.71 |
Dividend Per Share | 0.320 | 0.320 | 0.320 | 0.320 | 0.320 |
Dividend Growth | 0% | 0% | 0% | 0% | 0% |
Gross Margin | 66.24% | 66.51% | 66.76% | 67.76% | 68.57% |
Operating Margin | 21.21% | 21.75% | 21.45% | 24.73% | 25.24% |
Profit Margin | 14.97% | 6.02% | 14.50% | 25.09% | 24.60% |
Free Cash Flow Margin | 21.66% | 21.04% | 20.37% | 19.02% | 25.36% |
EBITDA | 355.05 | 331.14 | 313.72 | 344.05 | 339.53 |
EBITDA Margin | 29.22% | 27.15% | 27.07% | 30.27% | 30.71% |
D&A For EBITDA | 97.36 | 65.9 | 65.11 | 62.94 | 60.47 |
EBIT | 257.7 | 265.24 | 248.61 | 281.11 | 279.06 |
EBIT Margin | 21.21% | 21.75% | 21.45% | 24.73% | 25.24% |
Effective Tax Rate | 24.44% | 25.45% | 9.47% | 15.71% | 12.70% |
Advertising Expenses | - | 3.2 | 4.1 | 4.8 | 4.6 |